| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/31/2011 | EP2361910A1 Compound having tafia inhibitory activity |
| 08/31/2011 | EP2361907A1 The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof |
| 08/31/2011 | EP2361625A1 Methods and compositions for the treatment of hyperlipidemia |
| 08/31/2011 | EP2361618A2 Compositions for treating or preventing obesity and insulin resistance disorders |
| 08/31/2011 | EP2361513A1 DHA- and EPA-rich nutritional ingredient |
| 08/31/2011 | EP2187915B1 Use of the peptide phpfhlfvy (renin inhibitor) in anti-angiogenic therapy of certain diseases |
| 08/31/2011 | EP2073810B1 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer, autoimmune disorders and hiv infection |
| 08/31/2011 | EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 08/31/2011 | EP1523325B1 Methods and compositions for treating polycystic ovary syndrome |
| 08/31/2011 | EP1517694B1 Plant extracts |
| 08/31/2011 | EP1481671B1 Compositions and foods for improving lipid metabolism |
| 08/31/2011 | EP1320362B1 Stabilised fibrate microparticles |
| 08/31/2011 | CN1962695B GLP-1 infusion proteins, their preparation and use |
| 08/31/2011 | CN1918119B Bicycloester derivative |
| 08/31/2011 | CN102171329A Lactic acid bacterium having high oxalic acid decomposition ability |
| 08/31/2011 | CN102171214A Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 08/31/2011 | CN102171213A Pyrazolo [3, 4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity |
| 08/31/2011 | CN102171204A 8-substituted isoquinoline derivative and use thereof |
| 08/31/2011 | CN102171188A Tripyridyl carboxamide orexin receptor antagonists |
| 08/31/2011 | CN102170888A Paeoniflorin preparations and uses thereof for fat reduction |
| 08/31/2011 | CN102170878A Controlled release pharmaceutical composition |
| 08/31/2011 | CN102170876A Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient |
| 08/31/2011 | CN102170798A Composition for promoting control of total and LDL cholesterol and/or weight loss and/or thermogenesis |
| 08/31/2011 | CN102167753A Preparation method of oat beta-glucan |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166330A Medicament for treating hyperlipidemia and preparation thereof |
| 08/31/2011 | CN102166300A Traditional Chinese medicine preparation for treating pulmonary yin deficiency, gastric yin deficiency and diabetic yin deficiency |
| 08/31/2011 | CN102166297A Chinese medicinal formula for treating diabetes |
| 08/31/2011 | CN102166294A Common anemarrhena polysaccharide extractive and preparation method and medicinal purposes thereof |
| 08/31/2011 | CN102166293A Garlic oil navel paste and preparation method and application thereof |
| 08/31/2011 | CN102166292A Externally-applied Chinese medicinal preparation for losing weight and preparation method thereof |
| 08/31/2011 | CN102166287A Recovery mud moxibustion and preparation method |
| 08/31/2011 | CN102166274A Method for extracting alpha-glucosidase inhibitor of small intestines from China soapberry |
| 08/31/2011 | CN102166269A Method for extracting flavones from waste slags of citrus bergamot drink |
| 08/31/2011 | CN102166259A Method for preparing biflavone capsules and tablets |
| 08/31/2011 | CN102166258A Preparation method of slow-release micropill with mulberry leaf extract |
| 08/31/2011 | CN102166243A Artemisia rupestris preparation and application thereof in medicaments for treating diabetes |
| 08/31/2011 | CN102166239A Product for preventing and/or treating diabetes |
| 08/31/2011 | CN102166233A Oil-in-water type sea buckthorn oil nano-emulsion oral liquid and preparation method thereof |
| 08/31/2011 | CN102166215A Pharmaceutical composition containing piperazine derivatives |
| 08/31/2011 | CN102166211A Use of derivatives of 1-deoxynojiri mycin containing 1,2,3-triazoles as alpha-glucosidase inhibitors |
| 08/31/2011 | CN102166210A Use of derivatives of 1-deoxynojiri mycin as alpha-glucosidase inhibitors |
| 08/31/2011 | CN102166202A Double-layer osmotic pump controlled release tablet of gliquidone and preparation method thereof |
| 08/31/2011 | CN102166194A Preparation method of anthocyanidin pellet |
| 08/31/2011 | CN102166015A Preparation method of probiotics agent capable of lowering blood fat |
| 08/31/2011 | CN101926898B Plaque removing and fixing tablet for treating unstable carotid plaque |
| 08/31/2011 | CN101884693B Traditional Chinese medicine for treating diabetic eye diseases |
| 08/31/2011 | CN101837063B Lipid-lowering and weight-reducing buccal tablets |
| 08/31/2011 | CN101837062B Lipid-lowering buccal tablets |
| 08/31/2011 | CN101829079B Application of compound of (E)-5-[6-hydroxy-5-(3-methyl-1-butenyl)-2-benzofuranyl] phenyl-1, 3-diol to preparation of pancrelipase inhibitor |
| 08/31/2011 | CN101732371B Co-production extract method of fruit oil and polysaccharide from seabuckthorn fruit paste |
| 08/31/2011 | CN101590158B Method for extracting polyphenol from canna edulis ker waste residue |
| 08/31/2011 | CN101579382B Medicinal composition for treating diabetes mellitus and preparation method thereof |
| 08/31/2011 | CN101579380B Medicinal dripping pill for treating diabetes mellitus |
| 08/31/2011 | CN101570557B Compound in cyclocarya paliurus and application thereof in medicament field |
| 08/31/2011 | CN101570510B Quinoline compound, pharmaceutical composition, preparation method and application thereof |
| 08/31/2011 | CN101474291B Application of franchet groundcherry calyx or fruit saponin in preparing medicament and health product for treating diabetes |
| 08/31/2011 | CN101467983B Menatetrenone soft capsule and preparation method thereof |
| 08/31/2011 | CN101401939B Anti-activated state T cell antibody vaccine for preventing and/or treating immune correlated disease |
| 08/31/2011 | CN101337009B Use of water hyacinth extract in preparing lipid-lowering medicine |
| 08/31/2011 | CN101254238B Method for extracting alpha-glucosidase restraining agent effective ingredient from plants |
| 08/31/2011 | CN101248876B Norcholesterol health care drink |
| 08/31/2011 | CN101161270B Pharmaceutical composition of cattail pollen and kudzu root |
| 08/31/2011 | CN101062071B Total saponins from radix bupleuri extract and the preparing method thereof |
| 08/30/2011 | US8008513 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 08/30/2011 | US8008502 Thiazoline acid derivatives |
| 08/30/2011 | US8008332 Substituted indazoles as glucokinase activators |
| 08/30/2011 | US8008308 Phosphonate compounds |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | CA2645294C Dibenzyl amine compounds and derivatives |
| 08/30/2011 | CA2492021C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 08/30/2011 | CA2438717C 6-phenylbenzonaphthyridines |
| 08/30/2011 | CA2436407C Polymer conjugates of neublastin and methods of using same |
| 08/30/2011 | CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 08/30/2011 | CA2393352C Adamantane derivatives |
| 08/30/2011 | CA2331329C Diacylglycerol acyl transferase proteins |
| 08/25/2011 | WO2011103156A1 Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase |
| 08/25/2011 | WO2011103128A1 Treatment of metabolic syndrome with novel amines |
| 08/25/2011 | WO2011103127A1 Treatment of metabolic syndrome with piperidine amides |
| 08/25/2011 | WO2011103126A1 Treatment of metabolic syndrome with piperidine amides |
| 08/25/2011 | WO2011103123A2 Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities |
| 08/25/2011 | WO2011103055A1 Glycine sulfonamides for use as inhibitors of diacylglycerol lipase |
| 08/25/2011 | WO2011102690A2 Pharmaceutical composition for treating diabetes containing quamoclit angulata extracts |
| 08/25/2011 | WO2011102577A1 Novel use for scopolin and derivatives thereof |
| 08/25/2011 | WO2011102514A1 Aromatic ring compound |
| 08/25/2011 | WO2011102436A1 Tgf-β signal transduction inhibitor |
| 08/25/2011 | WO2011102035A1 Prophylactic/ameliorating agent for diseases, endurance improving agent and anti-fatigue agent, and pharmaceutical agent, food and beverage each comprising any one of those agents |
| 08/25/2011 | WO2011101424A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 08/25/2011 | WO2011100984A1 Gelatin, a curcumin drug carrier system |
| 08/25/2011 | WO2011100983A1 Casein, a novel curcumin drug carrier system |
| 08/25/2011 | WO2011041385A3 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis |
| 08/25/2011 | WO2011025996A9 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 08/25/2011 | WO2011013987A3 2,2-disubstituted-2h-chromene compound |
| 08/25/2011 | US20110208673 Antibodies to lymphotoxin-alpha |
| 08/25/2011 | US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage |
| 08/25/2011 | US20110207810 N1-benzo[1,3]dioxol-5-ylmethyl-n2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing same |
| 08/25/2011 | US20110207805 Composition of flavanolignan and amino acid with improved water solubility |
| 08/25/2011 | US20110207799 Compositions for Targeted Delivery of siRNA |
| 08/25/2011 | US20110207797 Enhanced antisense oligonucleotides |